Get started
Source

Exploration of Endocrine and Metabolic Diseases

ISSN: 2998-2456
Source type: journal
Publisher:
Fully OA: Yes
DOAJ: Yes
OpenAlex ID: S5407042728
Waist-to-height ratio as a novel marker of metabolic syndrome in patients with type 2 diabetes mellitus
2025 · Elif Basaran, Gulali Aktas · Exploration of Endocrine and Metabolic Diseases · 42
PDF
The 2024 American Diabetes Association guidelines on Standards of Medical Care in Diabetes: key takeaways for laboratory
2024 · Dipti Tiwari, Tar Choon Aw · Exploration of Endocrine and Metabolic Diseases · 12
PDF
Updates from the 2025 American Diabetes Association guidelines on standards of medical care in diabetes
2025 · Dipti Tiwari, Wann Jia Loh, et al. · Exploration of Endocrine and Metabolic Diseases · 11
PDF
Synergistic glucocorticoids, vitamins, and microbiome strategies for gut protection in critical illness
2025 · Gianfranco Umberto Meduri · Exploration of Endocrine and Metabolic Diseases · 9
PDF
Four hepatic steatosis indices in predicting quantitative computed tomography-based metabolic dysfunction-associated fatty liver disease
2024 · Bingwu Xu, Cuihong Li, et al. · Exploration of Endocrine and Metabolic Diseases · 9
Glucocorticoid receptor alpha: origins and functions of the master regulator of homeostatic corrections in health and critical illness
2025 · Gianfranco Umberto Meduri · Exploration of Endocrine and Metabolic Diseases · 7
Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia
2024 · Eva B. van Dijk, Samantha L. Ginn, et al. · Exploration of Endocrine and Metabolic Diseases · 7
PDF
Metabolic syndrome in menopause
2025 · Nagamani Gumpeny, Lakshmi Gumpeny, et al. · Exploration of Endocrine and Metabolic Diseases · 6
PDF
Endogenous glucocorticoids during skeletal ageing
2024 · Eugenie Macfarlane, Hong Zhou, et al. · Exploration of Endocrine and Metabolic Diseases · 6
Psychotropic medications and metabolic side effects
2025 · Michael Natalizio, Sankalp Nigam, et al. · Exploration of Endocrine and Metabolic Diseases · 5
PDF
Hormonal changes during aging and their effects on quality of life
2025 · Carter Coggins, Shaan Patel, et al. · Exploration of Endocrine and Metabolic Diseases · 5
PDF
Gestational diabetes mellitus in India: metabolic burden, clinical gaps, and therapeutic opportunities—a systematic review
2025 · Sumedha Rajendra Zade, Sameer Uttamrao Khasbage, et al. · Exploration of Endocrine and Metabolic Diseases · 5
PDF
Healthy adipose tissue after menopause: contribution of balanced diet and physical exercise
2025 · Bruno Vecchiatto, Thiago L. Castro, et al. · Exploration of Endocrine and Metabolic Diseases · 5
Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition
2024 · Amar Mann, Richard C. Strange, et al. · Exploration of Endocrine and Metabolic Diseases · 4
PDF
Impaired cytokines in diabetes and diabetic foot ulcers: mechanisms and prospects
2026 · Arbab Alam, Sukhjinder Momi, et al. · Exploration of Endocrine and Metabolic Diseases · 3
PDF
Glucocorticoid receptor alpha as a core survival receptor: mechanisms, and implications for health and critical illness
2025 · G. Umberto Meduri · Exploration of Endocrine and Metabolic Diseases · 3
PDF
Glucocorticoid signalling coordinating circadian rhythms between the glymphatic system and sleep contributes to brain health
2025 · Laura C. A. van der Zwet, Stephan Michel, et al. · Exploration of Endocrine and Metabolic Diseases · 3
PDF
A comprehensive review on diabetes mellitus and heart failure
2025 · Isa Sincer · Exploration of Endocrine and Metabolic Diseases · 3
PDF
Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques
2025 · Pirangi Srikanth, Khaja Moinuddin Shaik, et al. · Exploration of Endocrine and Metabolic Diseases · 3
Testosterone undecanoate is associated with improved ageing male symptoms score in men with type 2 diabetes and adult-onset testosterone deficiency: re-analyzed results from a randomised controlled trial
2024 · Pravinath Ramachandran, Michael Zitzmann, et al. · Exploration of Endocrine and Metabolic Diseases · 3
The role of the resveratrol-sirtuin axis in the treatment of metabolic dysfunction-associated diseases
2026 · Jiale Yang, Shuping Chen, et al. · Exploration of Endocrine and Metabolic Diseases · 2
PDF
Circadian rhythm modulation in metabolic disease: targeting clock genes for obesity and insulin resistance
2026 · Muhammad Hammad, Khadija Shakoor · Exploration of Endocrine and Metabolic Diseases · 2
PDF
Normal triglyceride levels are positively associated with plasma glucose levels and type 2 diabetes diagnosis in Chinese adults
2026 · Yutang Wang, Hongying Liu, et al. · Exploration of Endocrine and Metabolic Diseases · 2
PDF
Osteoporosis: definition, diagnosis, and considerations prior to starting treatment
2026 · Maritza Vidal, Nancy E. Lane · Exploration of Endocrine and Metabolic Diseases · 2
PDF
A novel therapeutic strategy of obesity from the perspective of SPMs
2026 · Ze-Wei Zhao · Exploration of Endocrine and Metabolic Diseases · 2
PDF
Works count: 80
Citation count: 181
H-index: 7
I10-index: 3
2yr mean citedness: 2.291
Year
Topic
Type